Showing results (671-680 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1997
The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validityA H Clayton, E L McGarvey, G J ClavetPsychopharmacology Bulletin|January 1, 1997
Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoriaM Steiner, M Korzekwa, J Lamont, et al.Psychopharmacology Bulletin|November 11, 2003
The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapyAndrea de Bartolomeis, Felice IasevoliPsychopharmacology Bulletin|November 11, 2003
Acute cortisol administration triggers craving in individuals with cocaine dependenceIgor Elman, Scott E Lukas, Katherine H Karlsgodt, et al.Psychopharmacology Bulletin|November 11, 2003
Disturbed glucose metabolism among patients taking olanzapine and typical antipsychoticsBoadie W Dunlop, Maya Sternberg, Lawrence S Phillips, et al.Psychopharmacology Bulletin|November 11, 2003
Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placeboPhebe Tucker, Robin Potter-Kimball, Dorothy B Wyatt, et al.Psychopharmacology Bulletin|October 21, 2003
Neuropharmacology of paroxetineCharles B Nemeroff, Michael J OwensPsychopharmacology Bulletin|October 21, 2003
In vivo neuroimaging correlates of the efficacy of paroxetine in the treatment of mood and anxiety disordersClinton KiltsPsychopharmacology Bulletin|October 21, 2003
Paroxetine treatment of major depressive disorderMartin B KellerPsychopharmacology Bulletin|October 21, 2003
Treatment of panic disorder: focus on paroxetineMark H Pollack, Alicia C DoylePageof 128